Pluripotent Stem Cell Suspension Culture With WNT Dose Control

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing methods for producing pluripotent stem cells face challenges in scalability and productivity, particularly in suspension culture due to high frequency of undifferentiation-deviated cells, which are not adequately addressed by existing methods focusing on WNT protein concentration in the medium.

Innovation Solution

The method involves maintaining the amount of WNT protein in the medium at a specific threshold (2.9×10² μg/mL·cm² or less) per unit area of the cell surface and limiting the WNT protein per 10⁴ cells to 1.0 pg, using a medium containing specific factors like L-ascorbic acid, insulin, and a ROCK inhibitor, and forming cell aggregates during suspension culture.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If suspension culture is used to improve scalability and cell yield, then productivity increases, but the frequency of undifferentiation-deviated cells increases

Engineering Contradiction:
Improvecell yieldVSAvoidundifferentiation-deviated cell frequency
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The invention changes the parameter of WNT protein concentration in the culture medium from conventional high concentrations to specifically controlled low concentrations (0.01-10 ng/mL), which resolves the contradiction by enabling suspension culture scalability while preventing undifferentiation-deviated cell formation through precise parameter control

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The invention implements feedback control by monitoring WNT protein levels in the medium and adjusting supplementation accordingly, creating a closed-loop system that maintains optimal WNT concentrations to prevent undifferentiation while enabling high-cell-yield suspension culture

Inventive Principle:
Principle #23Feedback

2Reliability

If WNT protein concentration in medium is increased to maintain pluripotency, then cell undifferentiation is prevented, but the harmful effect of undifferentiation-deviated cells increases

Engineering Contradiction:
Improvepluripotency maintenanceVSAvoidundifferentiation-deviated cell formation
Core Design Contradiction:
ReliabilityVSObject-generated harmful factors

Solution Approach 1:

The invention fundamentally changes the WNT protein concentration parameter from conventional high levels to specifically controlled low levels (0.01-10 ng/mL), which prevents undifferentiation-deviated cell formation while maintaining pluripotency through this counterintuitive parameter reversal

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The invention applies partial action by providing only sufficient WNT protein at low concentrations rather than excessive high concentrations, which is just enough to maintain pluripotency and prevent harmful cell differentiation while avoiding the negative effects of excess WNT protein

Inventive Principle:
Principle #16Partial or excessive action

3Reliability

If adhesion culture is used to prevent undifferentiation-deviated cells, then cell homogeneity is maintained, but scalability and productivity are limited

Engineering Contradiction:
Improvecell homogeneityVSAvoidscalability
Core Design Contradiction:
ReliabilityVSProductivity

Solution Approach 1:

The invention changes the culture method parameter from adhesion culture to suspension culture, combined with controlling WNT protein concentration at low levels (0.01-10 ng/mL), which enables both high scalability and cell homogeneity by preventing undifferentiation in the suspension system

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The invention creates a simplified model system using suspension culture that copies the beneficial homogeneous differentiation characteristics of adhesion culture while adding the scalability advantage, effectively replicating the success of adhesion culture in a more scalable format

Inventive Principle:
Principle #26Copying

Data Source

PatentUS12534705B2Method for producing pluripotent stem cells
Publication Date: 2026.01.27 KANEKA CORP
  • US12534705B2 patent drawing
  • US12534705B2 patent drawing
  • US12534705B2 patent drawing

AI summary

A method for producing pluripotent stem cells includes a step of performing suspension culture of pluripotent stem cells under a condition in which an amount, which is calculated by the following Equation (1), of WNT protein contained in a unit of a medium in contact with a unit area of a cell surface of a pluripotent stem cell is maintained at 2.9×102 μg/mL·cm2 or less.(Amount of WNT protein contained in unit of medium in contact with unit area of cell surface)=(concentration of WNT protein in medium)/(surface area in contact with medium per cell)  (1)